• Explore /
  • Poster
  • / Randomized, parallel arm, phase II study of telotristat (Xermelo) in combination with lutetium Lu 177 dotatate (Lutathera) in well-differentiated neuroendocrine tumors (NETs).

Randomized, parallel arm, phase II study of telotristat (Xermelo) in combination with lutetium Lu 177 dotatate (Lutathera) in well-differentiated neuroendocrine tumors (NETs).

Abstract Poster

Authors

null

Aman Chauhan

UK Markey Cancer Center, University of Kentucky, Lexington, KY

Aman Chauhan , Charles Kunos , Donglin Yan , Aman Khurana , Riham Khouli , Michael J. Cavnar , Prakash Pandalai , Joseph Kim , Lowell Brian Anthony

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Other

Clinical Trial Registration Number

NCT04543955

DOI

10.1200/JCO.2022.40.4_suppl.TPS516

Abstract #

TPS516

Poster Bd #

P7

Abstract Disclosures

Similar Posters

First Author: Aman Chauhan

First Author: Michael Morse

First Author: Michael J. Demeure

First Author: Aman Chauhan